CA2292794A1 - Ace-inhibitor nitric salts - Google Patents

Ace-inhibitor nitric salts Download PDF

Info

Publication number
CA2292794A1
CA2292794A1 CA002292794A CA2292794A CA2292794A1 CA 2292794 A1 CA2292794 A1 CA 2292794A1 CA 002292794 A CA002292794 A CA 002292794A CA 2292794 A CA2292794 A CA 2292794A CA 2292794 A1 CA2292794 A1 CA 2292794A1
Authority
CA
Canada
Prior art keywords
iii
enalapril
residue
forms
nitric salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002292794A
Other languages
English (en)
French (fr)
Inventor
Piero Del Soldato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicox SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2292794A1 publication Critical patent/CA2292794A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0217—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -C(=O)-C-N-C(=O)-N-C-C(=O)-
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
CA002292794A 1997-06-27 1998-06-24 Ace-inhibitor nitric salts Abandoned CA2292794A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT97MI001523A IT1292426B1 (it) 1997-06-27 1997-06-27 Sali nitrati di ace-inibitori
ITMI97A001523 1997-06-27
PCT/EP1998/003946 WO1999000361A1 (en) 1997-06-27 1998-06-24 Ace-inhibitor nitric salts

Publications (1)

Publication Number Publication Date
CA2292794A1 true CA2292794A1 (en) 1999-01-07

Family

ID=11377450

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002292794A Abandoned CA2292794A1 (en) 1997-06-27 1998-06-24 Ace-inhibitor nitric salts

Country Status (17)

Country Link
US (1) US6218417B1 (OSRAM)
EP (1) EP1019370B1 (OSRAM)
JP (1) JP2002506456A (OSRAM)
KR (1) KR100512892B1 (OSRAM)
CN (1) CN1205186C (OSRAM)
AT (1) ATE230393T1 (OSRAM)
AU (1) AU740411B2 (OSRAM)
BR (1) BR9810459A (OSRAM)
CA (1) CA2292794A1 (OSRAM)
DE (1) DE69810498T2 (OSRAM)
DK (1) DK1019370T3 (OSRAM)
ES (1) ES2190095T3 (OSRAM)
HU (1) HUP0003133A3 (OSRAM)
IL (1) IL132691A (OSRAM)
IT (1) IT1292426B1 (OSRAM)
RU (1) RU2194037C2 (OSRAM)
WO (1) WO1999000361A1 (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1301759B1 (it) * 1998-06-19 2000-07-07 Nicox Sa Sali nitrati di farmaci antiipertensivi
IT1303672B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei
US6465463B1 (en) 1999-09-08 2002-10-15 Nitromed, Inc. Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
AU780261B2 (en) 1999-10-29 2005-03-10 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US7537785B2 (en) 1999-10-29 2009-05-26 Nitromed, Inc. Composition for treating vascular diseases characterized by nitric oxide insufficiency
US7708989B2 (en) 1999-10-29 2010-05-04 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US7235237B2 (en) 1999-10-29 2007-06-26 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
AU2002338528B2 (en) 2001-05-02 2008-01-24 Nicox S.A. Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
BR0307420A (pt) 2002-02-04 2004-12-21 Werner Haas Compostos, composições farmacêuticas e métodos para impedir e/ou tratar doença em mamìfero
EP1562975A2 (en) * 2002-10-25 2005-08-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
US7169805B2 (en) * 2003-05-28 2007-01-30 Nicox S.A. Captopril derivatives
SI21704A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia
AU2005274763A1 (en) * 2004-07-16 2006-02-23 Nitromed, Inc. Compositions and methods related to heart failure
AU2005276624B2 (en) * 2004-08-25 2011-09-29 Actelion Pharmaceuticals Ltd. Bicyclononene derivatives as renin inhibitors
ES2314583T4 (es) * 2005-01-06 2009-05-18 Ipca Laboratories Limited Proceso para sintesis de los derivados del acido (2s,3as,7as)-1-(s)-alanil-octahidro-1h-indol-2-carboxilico y su utilizacion en la sintesis de perindropil.
CA2606880A1 (en) * 2005-05-05 2006-11-16 Keryx Biopharmaceuticals, Inc. Combination therapy with sulodexide and a blood pressure reducing agent in the treatment of diabetic nephropathy
BRPI0609890A2 (pt) * 2005-05-27 2010-05-04 Actelion Pharmaceuticals Ltd composto, composição farmacêutica, e, uso de um composto
GB0511686D0 (en) * 2005-06-08 2005-07-13 Novartis Ag Organic compounds
WO2007045551A2 (en) * 2005-10-18 2007-04-26 Nicox S.A. Renin inhibitors nitroderivatives
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
CA2637546A1 (en) 2006-02-02 2007-08-09 Actelion Pharmaceuticals Ltd Secondary amines as renin inhibitors
CA2634473A1 (en) * 2006-02-17 2007-08-30 Nitromed, Inc. Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
EP1994026A2 (en) * 2006-03-08 2008-11-26 Actelion Pharmaceuticals Ltd. New amines
EP2024337A4 (en) * 2006-05-16 2011-09-14 Nitromed Inc SOLID DOSAGE FORMULATIONS OF HYDRALAZIN COMPOUNDS
KR20130029116A (ko) 2008-05-05 2013-03-21 머크 샤프 앤드 돔 리미티드 레닌 억제제로서의 3,4-치환된 피페리딘 유도체
ES2656237T3 (es) 2011-04-19 2018-02-26 Alfama, Inc. Moléculas liberadoras de monóxido de carbono y usos de las mismas
ES2628634T3 (es) 2011-07-21 2017-08-03 Alfama, Inc. Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT377496B (de) * 1981-06-19 1985-03-25 Voith Gmbh J M Vorrichtung zum anwickeln einer warenbahn auf eine neu eingelegte wickelhuelse in einer doppeltragwalzen-wickelmaschine
SE463851B (sv) 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
US5352708A (en) 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5328933A (en) 1992-10-28 1994-07-12 Allergan, Inc. Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues
DE69433744T2 (de) * 1993-09-17 2004-10-14 Pfizer Inc. 3-amino-5-carboxy-substituierte piperidine und 3-amino-4-carboxy-substituierte pyrrolidine als tachykinin-antagonisten
US5861426A (en) 1994-05-10 1999-01-19 Nicox S.A. Nitro compounds of the formula A-Xi -NO2 and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities
WO1996028423A1 (fr) * 1995-03-15 1996-09-19 Sankyo Company, Limited Composes dipeptidiques de structure ahpba
US5625083A (en) 1995-06-02 1997-04-29 Bezuglov; Vladimir V. Dinitroglycerol esters of unsaturated fatty acids and prostaglandins
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
CN1141771A (zh) * 1995-08-02 1997-02-05 贾力 巯-亚硝基化合物及其医学用途

Also Published As

Publication number Publication date
KR20010013958A (ko) 2001-02-26
ITMI971523A1 (it) 1998-12-27
KR100512892B1 (ko) 2005-09-07
DK1019370T3 (da) 2003-05-05
EP1019370B1 (en) 2003-01-02
AU8730098A (en) 1999-01-19
DE69810498T2 (de) 2003-10-30
ATE230393T1 (de) 2003-01-15
IT1292426B1 (it) 1999-02-08
RU2194037C2 (ru) 2002-12-10
CN1260780A (zh) 2000-07-19
ES2190095T3 (es) 2003-07-16
US6218417B1 (en) 2001-04-17
WO1999000361A1 (en) 1999-01-07
IL132691A0 (en) 2001-03-19
HUP0003133A3 (en) 2002-10-28
IL132691A (en) 2004-06-01
DE69810498D1 (de) 2003-02-06
CN1205186C (zh) 2005-06-08
BR9810459A (pt) 2006-10-03
AU740411B2 (en) 2001-11-01
EP1019370A1 (en) 2000-07-19
ITMI971523A0 (OSRAM) 1997-06-27
HUP0003133A2 (en) 2001-03-28
JP2002506456A (ja) 2002-02-26

Similar Documents

Publication Publication Date Title
CA2292794A1 (en) Ace-inhibitor nitric salts
US4508729A (en) Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
KR960003615B1 (ko) 메틸 α-5(4,5,6,7-테트라하이드로(3,2-C)티에노 피리딜)(2-클로로페닐)-아세테이트의 우선성 광학이성체, 그 제법 및 그의 약제학적 조성물
DE69426376T2 (de) Substituierte Azepino (2,1-a)isochinolin Verbindungen
AU726585B2 (en) Biarylalkanoic acids as cell adhesion inhibitors
JPH05504775A (ja) トロンビンの阻害剤および基質
US4397857A (en) Azabicyclooctane-carboxylic acids and pharmaceutical compositions containing them and antihypertensive use thereof
JPH0442400B2 (OSRAM)
IE51821B1 (en) Substituted imino-diacids,their preparation and pharmaceutical compositions containing them
JPH01125398A (ja) アミノ酸誘導体およびその製法
FR2540118A1 (fr) Nouvelles amidines
US4468396A (en) Antihypertensive benzothiadiazines
DK149063B (da) Analogifremgangsmaade til fremstilling af trh-analoge derivater af histidylprolinamid eller farmaceutisk acceptable syreadditionssalte deraf
US4565819A (en) Substituted imino diacids, their preparation and pharmaceutical compositions which contain them
WO2003076457A1 (de) HEMMSTOFFE DES GERINNUNGSFAKTORS Xa, IHRE HERSTELLUNG UND VERWENDUNG
JPH09500113A (ja) エンケファリナーゼ及びａｃｅのインヒビターとして有用な抗高血圧性三環式アゼピン誘導体
HU187808B (en) Process for the preparation of n-bracket-carboxy-alkyl-bracket-prolina containing tripeptides
EP0059966B1 (en) Substituted thiazolidine carboxylic acid analogs and derivatives as antihypertensives
US4616030A (en) Perhydroindole-2-carboxylic acids as antihypertensives
US4616029A (en) Perhydromdole-2-carboxylic acids as antihypertensives
US4616031A (en) Perhydroindole-2-carboxylic acids as antihypertensives
US4644008A (en) Perhydroindole-2-carboxylic acids as antihypertensives
SK279617B6 (sk) Trifluórmetylmerkaptánové a merkaptoacylové derivá
IE59185B1 (en) New derivatives of bicyclic amino acids, a process for their preparation, agents containing them and their use
CN104311443B (zh) 一类含萘环的丁二酸酰胺衍生物、其制备方法及用途

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued